Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;10(10):1063-1076.
doi: 10.1002/ueg2.12350. Epub 2022 Dec 8.

The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries

Affiliations
Review

The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries

Satimai Aniwan et al. United European Gastroenterol J. 2022 Dec.

Abstract

Inflammatory bowel disease (IBD), which comprises Crohn's disease and ulcerative colitis, is an idiopathic inflammatory condition of the gastrointestinal tract. The incidence and prevalence of IBD are rapidly increasing worldwide, particularly in newly industrialized regions such as Asia. Although a large medical armamentarium is available for treating this chronic disease, IBD imposes a marked global disease burden. To understand the complex etiopathogenesis of this condition, it is important to consider the rapidly changing trends in its epidemiology in Asia. During the past few decades, the incidence and prevalence of IBD have significantly increased in both Asian countries and Asian immigrants in Western countries. In this review, we aimed to study and update the epidemiology of IBD in diverse Asian regions and among Asian immigrants in North America and Europe. Moreover, we highlighted that this population exhibits a unique disease phenotype, such as male predominance and high frequency of perianal fistula in Crohn's disease. Also, a different disease phenotype including more complicated disease such as perianal complications was noted in Asian Americans and Asian Europeans.

Keywords: Asia; epidemiology; immigrants; inflammatory bowel disease.

PubMed Disclaimer

Conflict of interest statement

Edward V. Loftus has consulted for AbbVie, Amgen, Arena, Boehringer Ingelheim, Bristol‐Myers Squibb, CALIBR, Celgene, Eli Lilly, Fresenius Kabi, Genentech, Gilead, Gossamer Bio, Iterative Scopes, Janssen, Morphic, Ono Pharma, Pfizer, Protagonist, Scipher Medicine, Sun Pharma, Surrozen, Takeda, and UCB; and has received research support from AbbVie, Bristol‐Myers Squibb, Celgene/Receptos, Genentech, Gilead, Gossamer Bio, Janssen, Pfizer, Robarts Clinical Trials, Takeda, Theravance, and UCB.

Similar articles

Cited by

References

    1. Aniwan S, Park SH, Loftus EV, Jr . Epidemiology, natural history, and risk stratification of Crohn's disease. Gastroenterol Clin North Am. 2017;46(3):463–80. 10.1016/j.gtc.2017.05.003 - DOI - PubMed
    1. Park SH. Update on the epidemiology of inflammatory bowel disease in Asia: where are we now? Intest Res. 2022;20(2):159–64. 10.5217/ir.2021.00115 - DOI - PMC - PubMed
    1. East Asia population 2022 12 [cited 2022 May 15]. https://www.worldometers.info/world‐population/eastern‐asia‐population/
    1. Park SH, Kim YJ, Rhee KH, Kim YH, Hong SN, Kim KH, et al. A 30‐year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa‐Kangdong district of Seoul, Korea in 1986‐2015. J Crohns Colitis. 2019;13(11):1410–17. 10.1093/ecco-jcc/jjz081 - DOI - PubMed
    1. Yoshida Y, Murata Y. Inflammatory bowel disease in Japan: studies of epidemiology and etiopathogenesis. Med Clin North Am. 1990;74(1):67–90. 10.1016/s0025-7125(16)30587-9 - DOI - PubMed

Publication types